Results 91 to 100 of about 71,360 (115)

Phase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease

International Journal of COPD
Ednan K Bajwa,1 Dawn Cislak,1 Amit Kumar,1 Dan Li,1 Eric J Messina,1 Tom Reynders,2 Jean-François Denef,2 Vasile Corcea,3 Ketan P Buch,4 Eseng Lai,1 S Aubrey Stoch1 1MRL, Merck & Co., Inc., Rahway, NJ, USA; 2Translational Medicine, MSD Belgium, Brussels,
Bajwa EK, Cislak D, Kumar A, Li D, Messina EJ, Reynders T, Denef JF, Corcea V, Buch KP, Lai E, Stoch SA   +10 more
doaj  

Leitrim in the district of the City of Sydney about a quarter of a mile from the boundary stone [cartographic material] : the property of D. Chambers Esq to be sold by Stubbs 1843 /

Plan of allotments and Chambers property showing layout of house, vineyard, driveway and ponds with names of adjoining landholders.; Also available in an electronic version via the Internet at: http://nla.gov.au/nla.map-f779; Ferguson Collection Map F ...
Pettingell.
core  

Exploring the optimal indwelling pleural catheter drainage technique in India

Lung India
Vikas Marwah, Robin Choudhary
doaj   +1 more source

A young lady with multiple lung nodules

Lung India
Afshan Shaik, Mahismita Patro, Ranjan Patel, Aswathy Girija, Sourin Bhuniya   +4 more
doaj   +1 more source

“Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms.” S. Malenfant, M. Lebret, É. Breton-Gagnon, et al. Eur Respir Rev 2021; 30: 200284.

European Respiratory Review
doaj   +1 more source

Rapamycin and CCI-779 inhibit the mammalian target of rapamycin signalling in hepatocellular carcinoma [PDF]

Liver International, 2010
Background: The mammalian target of rapamycin (mTOR), which phosphorylates p70S6K and 4EBP1 and activates the protein translation process, is upregulated in cancers and its activation may be involved in cancer development.
Edmund Kwok-Kwan Tung, Karen Man-Fong Sze, Yick-Pang Ching   +2 more
exaly   +2 more sources

Combination of Temsirolimus (CCI-779) with Chemoradiation in Newly Diagnosed Glioblastoma Multiforme (GBM) (NCCTG trial N027D) Is Associated with Increased Infectious Risks

Clinical Cancer Research, 2010
Purpose: The mammalian target of rapamycin (mTOR) functions within the phosphoinositide 3-kinase/Akt signaling pathway as a critical modulator of cell survival.
Allan B Dietz, Michael P Gustafson, Ravi D Rao   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Phase I and pharmacokinetic study of CCI-779, a novel cytostatic cell-cycle inhibitor, in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumors

Annals of Oncology, 2003
J Boni
exaly  

CCI-779 Inhibits Rhabdomyosarcoma Xenograft Growth by an Antiangiogenic Mechanism Linked to the Targeting of mTOR/Hif-1α/VEGF Signaling

Neoplasia, 2006
Na Shen, Arnulfo Mendoza, Chand Khanna   +2 more
exaly  

CCI‐779 in metastatic melanoma

Cancer, 2005
Kim Margolin, Jeffrey Longmate, Tim Synold   +2 more
exaly